Janney Montgomery Scott Starts Recro Pharma (REPH) at Buy

August 29, 2016 6:55 AM EDT
Get Alerts REPH Hot Sheet
Price: $7.20 --0%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 27 | New: 17
Trade REPH Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Janney Montgomery Scott initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.

Shares of Recro Pharma closed at $9.15 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot New Coverage, New Coverage

Related Entities

Janney Montgomery Scott

Add Your Comment